Osteoanabolic activity of whey-derived anti-oxidative (MHIRL and YVEEL) and angiotensin-converting enzyme inhibitory (YLLF, ALPMHIR, IPA and WLAHK) bioactive peptides

Peptides

Volumn 99, Issue , 2018, Pages 1-7

  Pandey, Masum ^a   Kapila, Rajeev ^a   Kapila, Suman ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Differentiation; Osteoblast; Osteoporosis; Peptides; Whey

Indexed keywords

ALKALINE PHOSPHATASE; ALPMHIR PEPTIDE; ANABOLIC AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IPA PEPTIDE; MHIRL PEPTIDE; OSTEOCALCIN; PEPTIDE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; WHEY PROTEIN; WLAHK PEPTIDE; YLLF PEPTIDE; YVEEL PEPTIDE; ANTIOXIDANT; DIFFERENTIATION ANTIGEN; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CALVARIA; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; MARKER GENE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WHEY; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG EFFECT; METABOLISM; OSTEOPOROSIS; PATHOLOGY; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGENS, DIFFERENTIATION; ANTIOXIDANTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; OLIGOPEPTIDES; OSTEOBLASTS; OSTEOPOROSIS; RATS; WHEY;

EID: 85033597930     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2017.11.004     Document Type: Article

References (45)

1. Fukushima, N., Hiraoka, K., Shirachi, I., Kojima, M., Nagata, K., Isolation and characterization of a novel peptide osteoblast activating peptide (OBAP), associated with osteoblast differentiation and bone formation. Biochem. Biophys. Res. Commun. 400 (2010), 157–163.
2. Xu, R., Effect of whey protein on the proliferation and differentiation of osteoblasts. J. Dairy Sci. 92 (2009), 3014–3018.
3. Armas, L.A., Recker, R.R., Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol. Metab. Clin. North Am. 41 (2012), 475–486.
4. Brandelli, A., Daroit, D.J., Corrêa, A.P.F., Whey as a source of peptides with remarkable biological activities. Food Res. Int. 73 (2015), 149–161.
5. Kennel, K.A., Drake, M.T., Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management, Mayo Clinic Proceedings. 2009, Elsevier, 632–638.
6. Elwood, P.C., Pickering, J.E., Fehily, A.M., Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J. Epidemiol. Commun. Health 61 (2007), 695–698.
7. Hoffman, J.R., Falvo, M.J., Protein-which is best?. J. Sports Sci. Med., 3, 2004, 118.
8. Madureira, A.R., Pereira, C.I., Gomes, A.M., Pintado, M.E., Malcata, F.X., Bovine whey proteins-Overview on their main biological properties. Food Res. Int. 40:10 (2007), 1197–1211.
9. Badr, G., Camel whey protein enhances diabetic wound healing in a streptozotocin-induced diabetic mouse model: the critical role of β-Defensin-1,−2 and-3. Lipids Health Dis., 12, 2013, 46.
10. Badr, G., Supplementation with undenatured whey protein during diabetes mellitus improves the healing and closure of diabetic wounds through the rescue of functional long-lived wound macrophages. Cell. Physiol. Biochem., 29, 2012, 571.
11. Badr, G., Mohany, M., Metwalli, A., Effects of undenatured whey protein supplementation on CXCL12-and CCL21-mediated B and T cell chemotaxis in diabetic mice. Lipids Health Dis., 10, 2011, 203.
12. Keri Marshall, N., Therapeutic applications of whey protein. Altern. Med. Rev. 9:2 (2004), 136–156.
13. Tulipano, G., Cocchi, D., Caroli, A.M., Comparison of goat and sheep β-lactoglobulin to bovine β-lactoglobulin as potential source of dipeptidyl peptidase IV (DPP-4) inhibitors. Int. Dairy J. 24 (2012), 97–101.
14. Takada, Y., Aoe, S., Kumegawa, M., Whey protein stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 223 (1996), 445–449.
15. Takada, Y., Matsuyama, H., Kato, K., Kobayashi, N., Yamamura, J.-I., Yahiro, M., Ace, S., Milk whey protein enhances the bone breaking force in ovariectomized rats. Nutr. Res. 17 (1997), 1709–1720.
16. Toba, Y., Takada, Y., Yamamura, J., Tanaka, M., Matsuoka, Y., Kawakami, H., Itabashi, A., Aoe, S., Kumegawa, M., Milk basic protein: a novel protective function of milk against osteoporosis. Bone 27 (2000), 403–408.
17. Kelly, O., Cusack, S., Cashman, K.D., The effect of bovine whey protein on ectopic bone formation in young growing rats. Br. J. Nutr. 90:3 (2003), 557–564.
18. Kruger, M.C., Plimmer, G.G., Schollum, L.M., Haggarty, N., Ram, S., Palmano, K., The effect of whey acidic protein fractions on bone loss in the ovariectomised rat. Br. J. Nutr. 94 (2005), 244–252.
19. Aoe, S., Toba, Y., Yamamura, J.I., Kawakami, H., Yahiro, M., Kumegawa, M., Itabashi, A., Takada, Y., Controlled trial of the effects of milk basic protein (MBP) supplementation on bone metabolism in healthy adult women. Biosci. Biotechnol. Biochem. 65 (2001), 913–918.
20. Reddi, S., Kumar, N., Vij, R., Mada, S.B., Kapila, S., Kapila, R., Akt drives buffalo casein-derived novel peptide-mediated osteoblast differentiation. J. Nutr. Biochem. 38 (2016), 134–144.
21. Reddi, S., Shanmugam, V.P., Tanedjeu, K.S., Kapila, S., Kapila, R., Effect of buffalo casein-derived novel bioactive peptides on osteoblast differentiation. Eur. J. Nutr., 2016, 1–13.
22. Behera, P., Kumar, R., Sandeep, I., Kapila, R., Dang, A.K., Kapila, S., Casein hydrolysates enhance osteoblast proliferation and differentiation in mouse bone marrow culture. Food Biosci. 2 (2013), 24–30.
23. Agarwal, S., Morshed, M., Labour, M.N., Hoey, D., Duffy, B., Curtin, J., Jaiswal, S., Enhanced corrosion protection and biocompatibility of a PLGA-silane coating on AZ31 Mg alloy for orthopaedic applications. RSC Adv. 6 (2016), 113871–113883.
24. Spreafico, A., Frediani, B., Capperucci, C., Leonini, A., Gambera, D., Ferrata, P., Rosini, S., Di Stefano, A., Galeazzi, M., Marcolongo, R., Osteogenic growth peptide effects on primary human osteoblast cultures: Potential relevance for the treatment of glucocorticoid-induced osteoporosis. J. Cell. Biochem. 98 (2006), 1007–1020.
25. Chaturvedi, R., Singha, P.K., Dey, S., Water soluble bioactives of nacre mediate antioxidant activity and osteoblast differentiation. PLoS One, 8, 2013, e84584.
26. Liu, J., Zhang, B., Song, S., Ma, M., Si, S., Wang, Y., Xu, B., Feng, K., Wu, J., Guo, Y., Bovine collagen peptides compounds promote the proliferation and differentiation of MC3T3-E1 pre-osteoblasts. PLoS One, 9, 2014, e99920.
27. Popovic, M.R., Dimic, A., Tasic, I., Hypertension and osteoporosis in postmenopausal women: 1b. 10. J. Hypertens., 29, 2011, e7.
28. Klagsbrun, M., Neumann, J., Tapper, D., The mitogenic activity of human breast milk. J. Surg. Res. 26 (1979), 417–422.
29. Hashizume, S., Kuroda, K., Murakami, H., Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium. Biochimica et Biophysica Acta (BBA)-Mol. Cell Res. 763 (1983), 377–382.
30. Francis, G.L., Regester, G.O., Webb, H., Ballard, F.J., Extraction from cheese whey by cation-exchange chromatography of factors that stimulate the growth of mammalian cells. J. Dairy Sci. 78 (1995), 1209–1218.
31. Reddi, S., Shanmugam, V.P., Kapila, S., Kapila, R., Identification of buffalo casein-derived bioactive peptides with osteoblast proliferation activity. Eur. Food Res. Technol. 242 (2016), 2139–2146.
32. Korhonen, H., Milk-derived bioactive peptides: from science to applications. J. Funct. Foods 1 (2009), 177–187.
33. Vij, R., Reddi, S., Kapila, S., Kapila, R., Transepithelial transport of milk derived bioactive peptide VLPVPQK. Food Chem. 190 (2016), 681–688.
34. Mada, S.B., Reddi, S., Kumar, N., Kumar, R., Kapila, S., Kapila, R., Trivedi, R., Karvande, A., Ahmad, N., Antioxidative peptide from milk exhibits antiosteopenic effects through inhibition of oxidative damage and bone-resorbing cytokines in ovariectomized rats. Nutrition 43 (2017), 21–31.
35. Wang, B., Li, B., Effect of molecular weight on the transepithelial transport and peptidase degradation of casein-derived peptides by using Caco-2 cell model. Food Chem. 218 (2017), 1–8.
36. Yamada, A., Sakurai, T., Ochi, D., Mitsuyama, E., Yamauchi, K., Abe, F., Novel angiotensin I-converting enzyme inhibitory peptide derived from bovine casein. Food Chem. 141 (2013), 3781–3789.
37. Owen, T.A., Aronow, M., Shalhoub, V., Barone, L.M., Wilming, L., Tassinari, M.S., Kennedy, M.B., Pockwinse, S., Lian, J.B., Stein, G.S., Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143 (1990), 420–430.
38. Beck, G.R. Jr., Zerler, B., Moran, E., Gene array analysis of osteoblast differentiation. Cell Growth Differ.-Publ. Am. Assoc. Cancer Res. 12 (2001), 61–84.
39. Burrows, M., Liu, D., Moore, S., McKay, H., Bone microstructure at the distal tibia provides a strength advantage to males in late puberty: an HR-pQCT study. J. Bone Miner. Res. 25 (2010), 1423–1432.
40. Kim, H.K., Kim, J.H., Park, D.S., Park, K.S., Kang, S.S., Lee, J.S., Jeong, M.H., Yoon, T.R., Osteogenesis induced by a bone forming peptide from the prodomain region of BMP-7. Biomaterials 33 (2012), 7057–7063.
41. Lee, S., Hashimoto, J., Suzuki, T., Satoh, A., Kavanagh, B., Kumagai, T., Yamai, K., Ohta, S., Concentrated bovine-milk whey active protein (CBP) supplement-combined dynamic flamingo therapy (DFT) activates bone metabolism and bone-related factors. J. Diabetes Metab., 4, 2013, 251.
42. Tsuji-Naito, K., Jack, R.W., Concentrated bovine milk whey active proteins facilitate osteogenesis through activation of the JNK-ATF4 pathway. Biosci. Biotechnol. Biochem. 76 (2012), 1150–1154.
43. Wang, M., Deng, Y., Zhou, P., Luo, Z., Li, Q., Xie, B., Zhang, X., Chen, T., Pei, D., Tang, Z., In vitro culture and directed osteogenic differentiation of human pluripotent stem cells on peptides-decorated two-dimensional microenvironment. ACS Appl. Mater. Interfaces 7 (2015), 4560–4572.
44. Huttunen, M.M., Pekkinen, M., Ahlström, M.E., Lamberg-Allardt, C.J., Long-term effects of tripeptide Ile-Pro–Pro on osteoblast differentiation in vitro. J. Nutr. Biochem. 19 (2008), 708–715.
45. Tulipano, G., Bulgari, O., Chess, S., Nardone, A., Cocchi, D., Caroli, A., Direct effects of casein phosphopeptides on growth and differentiation of in vitro cultured osteoblastic cells (MC3T3-E1). Regul. Pept. 160 (2010), 168–174.